What is the TRIN stock price?

Trinity Capital Inc. (TRIN) latest quote: $17.89, as of 11/4/26 12:44 PM ET. Prices on Cylvex may be delayed.

How many analyst price targets for TRIN were reached?

5 of 5 published price targets for TRIN were reached within 12 months (100% reached); 0 are still open. Counts only — firm names and target values are shown to signed-in members.

How many firms publish price targets or ratings on TRIN?

5 firms have published price targets or ratings on TRIN that Cylvex tracks. Counts only — firm names and target values are shown to signed-in members.

Is this investment advice?

No. Cylvex is an educational and informational platform; nothing on this page is investment, financial or trading advice. Past analyst targets do not predict future results.

NYSE

TRIN

Trinity Capital Inc.

$17.89CS band Mixed

+0.84 (+4.90%) TodayNov 4, 12:44 PM ET

About TRIN

Trinity Capital Inc is an internally managed, closed-end, non-diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, capital appreciation through investments across five distinct vertical markets. The company is focused on achieving its investment objective by operating as a specialty lending company that provides debt, including loans, equipment financings, and asset-based lending, to growth-oriented companies, including institutional investor-backed companies. Its investment portfolio mainly comprises private companies that have begun to have success selling their products to the market and need additional capital to expand their operations and sales.

News

2 latest

Mon, Nov 2

Zacks Investment Research11/2/26

New Mountain Finance (NMFC) Matches Q3 Earnings Estimates

New Mountain Finance (NMFC) reported Q3 2026 earnings of $0.26 per share, matching consensus estimates but missing revenue expectations at $60.41 million. The company has underperformed the S&P 500 by 23.7% year-to-date.

NMFC NMFCZ

Tue, Oct 20

GlobeNewswire Inc.10/20/26

Route 92 Medical Announces $100 Million Corporate Debt Facility

Route 92 Medical, a neurovascular medical technology company, secured a $100 million senior secured debt facility from Trinity Capital Inc. to support its growth strategy and meet strong product demand. The company's integrated neurovascular platform features proprietary technologies including Tenzing delivery catheters and Monopoint, with products like HiPoint 88 receiving FDA clearance for acute ischemic stroke treatment.

Headlines open the publisher's site.